India Glycols Ltd Q3 FY22 Earnings Conference Call Insights

Key highlights from India Glycols Ltd (INDIAGLYCO) Q3 FY22 Earnings Concall

Q&A Highlights:

• On a question asked about lower margin by Saket Kapoor and how much the company has spent on the grain based distilleries as of now and what capex is due, Rupark Sarswat CEO answered that regarding grain distilleries the total capex size is INR300 crores and expects one of the distillery in Gorakhpur will start operation in April, while Kashipur will start from June. On capex, the company has done about INR100 crores.

• Makarand Tilloo from Makarand Tilloo Investments asked about grain based distilleries and if the company is planning to expand its capacity in future. Rupark Sarswat CEO answered that the company is planning and has already got permission from the government for 200 KLPD, another grain based distillery in Gorakhpur.

• Makarand Tilloo from Makarand Tilloo Investments also asked if the company is planning to utilize Shakumbari in any other way.  Rupark Sarswat CEO answered that the company is not planning anything now or in near future.

• Makarand from Makarand Tilloo Investments asked about the total capacity of grain based distilleries in the next two years. Rupark Sarswat CEO replied that the company has 110,000 TPA distilleries. 180,000 liters will produce from the Kashipur plant and 110,000 liters from Gorakhpur.

• Bajrang Bafna of Sunidhi Securities asked that where does the company see its growth for the next 2-3 years. Rupark Sarswat CEO answered that the company’s R&D will be focusing on creating new molecules and new process technologies that didn’t exist when the company had products based on petroleum crude.

• Rohit Nagraj with Emkay Global asked about the specialty amines progress. Rupark Sarswat CEO replied that initially the company will be looking at amines which use feedstock the company has. Also in amines portfolio there are a wide range of amines. However,  the company said it’s early days to comment on amines.

• Rohit Nagraj with Emkay Global asked about the technology for specialty amines. Rupark Sarswat CEO answered that as for technology for amines, the company already has in-house R&D. Only for backward integration, then the company would be requiring the partners for technology or will have to design technology.

• Faiz Memon of Fidelis Wealth asked about the current capacity utilization. Rupark Sarswat CEO said that it’s difficult to give a number on capacity utilization as it varies on product lines. In the portable spirit space, the company has planned and is right now augmenting capacities to cater to growth. For ethylene oxide, the company has adequate capacities for next few years of growth. For bio-based specialties, the company is in the process of putting up new faculties to add capacities.

• Marsal asked about the reason for the reduction in finance cost. Rupark Sarswat CEO replied that last year the finance cost was almost INR25 crore or INR30 crore per quarter that has come down to INR15 crore. This is due to prepayment of loan, swapping of some of high cost loan to low cost loan, and more utilization for the export credits.

• Keshav from RakSan Investors asked about plant meg technologies and its progress.  R.K. Khandal President replied that MEG can be produced only by two ways; by oxidizing ethylene to make meg and secondly carbon dioxide and hydrogen reacting to make meg. Some companies claim the reaction can be done from the CO2 coming from the atmosphere. INDIAGLYCO is not focusing on this kind of R&D as India is not on good standing as far as catalyst development is concerned.